Skip to main content

Table 3 Dosimetric changes in the OAR

From: Impact of adaptive intensity-modulated radiotherapy on the neutrophil-to-lymphocyte ratio in patients with nasopharyngeal carcinoma

OARs ART+IMRT new
No.Gy
IMRT new
No.Gy
P
PG-ips
 D50 26.11 ± 6.12 27.39 ± 7.19 0.021*
 Dmean 28.68 ± 5.99 29.80 ± 7.12 0.038*
PG-con
 D50 24.69 ± 3.92 25.95 ± 4.20 0.009*
 Dmean 27.10 ± 4.01 28.02 ± 4.38 0.034*
Skin
 D50 3.03 ± 3.18 14.88 ± 6.65 < 0.001*
 Dmean 21.22 ± 22.27 18.52 ± 4.21 0.491
 Dmax 70.64 ± 5.52 71.29 ± 5.41 0.076
  1. Abbreviations: OAR organs at risk, PGs parotid glands, Dmean mean dose, D50 dose to 50% of the volume, IMRT new the new IMRT, ART+IMRT new,the new ART+IMRT
  2. *P ≤ 0.05